| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/28/2004 | EP0883993B1 Antiviral materials |
| 04/28/2004 | EP0879824B1 Triterpene derivatives and remedy for liver diseases |
| 04/28/2004 | EP0840741B1 Pna-dna chimeras and pna synthons for their preparation |
| 04/28/2004 | EP0809515B1 Therapeutic inhibitor of vascular smooth muscle cells |
| 04/28/2004 | EP0782857B1 use of 4-acylaminopyridine derivatives in the manufacture of a medicament for treating cerebrovascular disorders |
| 04/28/2004 | EP0782455B1 Use of porphyrins in the treatment of multiple sclerosis |
| 04/28/2004 | EP0777498B1 Conjugates made of metal complexes and oligonucleotides |
| 04/28/2004 | EP0719253B1 3-amino-5-carboxy-substituted piperidines and 3-amino-4-carboxy-substituted pyrrolidines as tachykinin antagonists |
| 04/28/2004 | EP0655925B1 Anti-cancer therapeutic compositions containing whey protein concentrate |
| 04/28/2004 | EP0585366B1 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
| 04/28/2004 | EP0584068B2 Method and composition for ameliorating the adverse effects of aging |
| 04/28/2004 | EP0558648B1 Improved matrix metalloprotease inhibitors |
| 04/28/2004 | EP0513200B2 Method and compositions for the synthesis of bch-189 and related compounds |
| 04/28/2004 | CN1492917A Function cubic liquid crystalline phase precursor and its preparation and using method |
| 04/28/2004 | CN1492876A Amphoteric sterols and the use thereof |
| 04/28/2004 | CN1492875A TTK in diagnosis and as a therapeutic target in cancer |
| 04/28/2004 | CN1492874A Macrolide antibiotics |
| 04/28/2004 | CN1492873A Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 04/28/2004 | CN1492872A Tricycle quinolinone and tricycle quinoline as androgen receptor modulator compounds |
| 04/28/2004 | CN1492871A Isoxazoline derivatives as anti-depressants |
| 04/28/2004 | CN1492870A Xanthine derivative, production and use thereof as a medicament |
| 04/28/2004 | CN1492869A Tricyclic androgen receptor modulator compounds and method |
| 04/28/2004 | CN1492868A Quinuclidine carbamate derivatives and their use as m3 antigonists |
| 04/28/2004 | CN1492865A š�-lactam compounds, process for producing the same and serum cholesterol-lowering agents containing the same |
| 04/28/2004 | CN1492863A Heterocyclylalkylindole or azaindole compounds as 5-hydroxytryptamine-6 ligands |
| 04/28/2004 | CN1492861A Process for preparation of citalopram |
| 04/28/2004 | CN1492859A Pyrimidine acyclonucleoside derivatives, preparation method and use thereof |
| 04/28/2004 | CN1492852A N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD |
| 04/28/2004 | CN1492763A Compositions for delivering bisphosphonates |
| 04/28/2004 | CN1492762A Azoles as malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 04/28/2004 | CN1492761A Injectable pharmaceutical composition for treatment and reversal of erectile dysfunction |
| 04/28/2004 | CN1492760A 环糊精制剂 Cyclodextrin formulation |
| 04/28/2004 | CN1492759A Device and method for preventing or treating failure of hemodialysis vascular access and other vascular grafts |
| 04/28/2004 | CN1492758A Method and formula for anti-tumor and anti-matastatic effect |
| 04/28/2004 | CN1492757A Use of accelerated lymphocyte homing agents for manufacture of medicament for treating delayed graft function in tissue transplant |
| 04/28/2004 | CN1492756A Amphoteric liposomes and the use thereof |
| 04/28/2004 | CN1492754A Cosmetic or pharmaceutical agent |
| 04/28/2004 | CN1492735A Non invasive measurements of chemical substances |
| 04/28/2004 | CN1491950A Extracting process for bilobalide A, B, C and its preparation |
| 04/28/2004 | CN1491947A C10 ester carbonate substituted taxadane |
| 04/28/2004 | CN1491946A C 10 ester substituted taxadane |
| 04/28/2004 | CN1491944A 5-amino-8-methoxy quinolone carboxylic acid derivatives and its preparation |
| 04/28/2004 | CN1491941A Heterobicyclic sulfonamide derivative and sulfonic ester derivative |
| 04/28/2004 | CN1491715A Chewing tablet of fleece-flower root and preparing method |
| 04/28/2004 | CN1491709A Liquid medicine for treating burn |
| 04/28/2004 | CN1491674A Arctium fruit general lignin glycoside extracts for treating diabetic nephrosis or diabete |
| 04/28/2004 | CN1491665A Compound povidone iodine external use medicine |
| 04/28/2004 | CN1491664A Composite medicinal preparation containing inosine matters |
| 04/28/2004 | CN1491663A Oral administration preparation of total red peoniforin and its preparing method |
| 04/28/2004 | CN1491662A Injection of total red penoniforin and its preparing method |
| 04/28/2004 | CN1491661A Total penoniforn preparation and its use |
| 04/28/2004 | CN1491660A Use of 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-one-4H-1 benzopyranyl-7-hydroxy-beta-D-glucuronic acid in producing medicine |
| 04/28/2004 | CN1491659A Notoginseng total saponin powder injection and preparing process |
| 04/28/2004 | CN1491658A Notiginseng total saponin liposome and its preparation |
| 04/28/2004 | CN1491657A Medicinal composition for injection, preparation containing said medicinal composition and its preparing process |
| 04/28/2004 | CN1491656A Medicinal use of asiatic centella extract containing asiaticoside and hydroxy asiaticoside |
| 04/28/2004 | CN1491655A Composition for preventing and treating pig Eperythrozoa disease |
| 04/28/2004 | CN1491654A Process for preparing selenium aspirin enteric tablet and its use of resisting thrombosis |
| 04/28/2004 | CN1491653A New use of brassinolide in reversing multiple medicine resistance of tumour cell |
| 04/28/2004 | CN1491652A Chemical mixture and its use |
| 04/28/2004 | CN1491651A Use of 23-hydroxy betutic acid in preparing medicine for treating and preventing tumour and AIDS |
| 04/28/2004 | CN1491650A Pazufloxacin methane-sulfonate eye ointment and its producing process-anti-infection |
| 04/28/2004 | CN1491649A Compound external preparation containing capsicine and nucleoside analogue |
| 04/28/2004 | CN1491648A Pyrithioxine hydrochloride freeze-dried power injection and its preparing method |
| 04/28/2004 | CN1491647A Composition for percutaneous treating impotence and female sexual cold and preventing sextual disease |
| 04/28/2004 | CN1491646A Compound amino acid ferrous salt iron supplement agent and its producing method |
| 04/28/2004 | CN1491645A Compound preparation for improving acute wound heeling for local use |
| 04/28/2004 | CN1491644A Fibrauretine slow releasing prepn |
| 04/28/2004 | CN1491643A Medicine for treating and preventing tumour metastasis and using method |
| 04/28/2004 | CN1491627A Wet keeping dressing for wound medicine |
| 04/28/2004 | CN1147584C Modulators of tissue regeneration |
| 04/28/2004 | CN1147509C Polymer combining with phosphoric acid and its preparation |
| 04/28/2004 | CN1147504C New thrombin inhibitors, their preparation and use |
| 04/28/2004 | CN1147503C Method for preparing anti-cancer medicine total saponin of Glycyrrhisa uralensis |
| 04/28/2004 | CN1147502C Method for large-scale production of Di (uridine 5'-tetraphosphate) and salts thereof |
| 04/28/2004 | CN1147500C Novel derivatives from class of oleandomycin |
| 04/28/2004 | CN1147497C Methylenebisphosphonic acid derivs. |
| 04/28/2004 | CN1147495C Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents |
| 04/28/2004 | CN1147494C Novel benzodiazine compound, its preparation method and medicine composition containing them |
| 04/28/2004 | CN1147493C Oxazolo, thiazole and selenazolo [4,5-C]-quinolin-4-amines and analoges thereof and pharmaceutical composition containing them |
| 04/28/2004 | CN1147492C New metal protease inhibitors its preparing method and their medicinal composition containing them |
| 04/28/2004 | CN1147491C Acridine carboxylic ester compound, preparation and medicinal composition thereof |
| 04/28/2004 | CN1147490C Furanotetrapyridine derivatives and its medicinal compounds and their use in the treatment of neurodegenerative disease |
| 04/28/2004 | CN1147489C New bicyclo aminopyrazineone compound, its production process and medical composition containing them |
| 04/28/2004 | CN1147486C 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles |
| 04/28/2004 | CN1147485C Indoline derivatives useful as 5-HT-2C receptor antagonists |
| 04/28/2004 | CN1147483C Adamantane derivatives |
| 04/28/2004 | CN1147482C Substittued (dihydro) benzoxazole and (dihydro)benzoxazine compound and its preparation and medicine composite |
| 04/28/2004 | CN1147481C Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases |
| 04/28/2004 | CN1147477C Novel allylthiopyridazine derivatives and process for preparing the same |
| 04/28/2004 | CN1147476C Pyrazole derivatives as P-38 MAP kinase inhibitors |
| 04/28/2004 | CN1147475C Process for preparation of anti-malarial drugs |
| 04/28/2004 | CN1147472C Benzamide formulation with histone deacetylase inhibitor activity |
| 04/28/2004 | CN1147471C Renin inhibitors |
| 04/28/2004 | CN1147470C Novel 2,3,3A,4,9,9A hexahydro-8-hydroxy-1H-benz[f] indoles, a method for the production thereof, and their use as medicine |
| 04/28/2004 | CN1147466C Amide compounds, its prepn. method and application |
| 04/28/2004 | CN1147461C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof |
| 04/28/2004 | CN1147459C Galcium receptor-active compound |
| 04/28/2004 | CN1147329C Device for trandermal electrotransport delivery of fentanyl and sufentanil |
| 04/28/2004 | CN1147318C Recombined alpha-type interferon freeze-drying protective agent |